| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA671394 | F | Tested for the minimum inhibitory concentration required to reduce herpes simplex virus type 1 (HSV-1) strain F induced cytopathogenicity by 50%. | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 2. | ALA671396 | F | Tested for the minimum inhibitory concentration required to reduce herpes simplex virus type 1 (HSV-1) strain KOS induced cytopathogenicity by 50%. | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 3. | ALA671398 | F | Tested for the minimum inhibitory concentration required to reduce herpes simplex virus type 1 (HSV-1) strain McIntyre induced cytopathogenicity by 50%. | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 4. | ALA670808 | F | Tested for the minimum inhibitory concentration required to reduce herpes simplex virus type 1 (HSV-2) strain 196 induced cytopathogenicity by 50%. | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 5. | ALA670810 | F | Tested for the minimum inhibitory concentration required to reduce herpes simplex virus type 1 (HSV-2) strain G induced cytopathogenicity by 50%. | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 6. | ALA670812 | F | Tested for the minimum inhibitory concentration required to reduce herpes simplex virus type 1 (HSV-2) strain Lyons induced cytopathogenicity by 50%. | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 7. | ALA673540 | F | Tested for the minimum inhibitory concentration required to reduce herpes simplex virus type 1 (TK- / TK+ HSV-1) strain VMW-1837 induced cytopathogenicity by 50%. | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 8. | ALA676564 | F | Tested for the minimum inhibitory concentration required to reduce thymidine kinase deficient herpes simplex virus type 1 (TK- HSV-1) strain B2006 induced cytopathogenicity by 50%. | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 9. | ALA671426 | F | Tested for the minimum inhibitory concentration required to reduce vaccinia virus(VV) induced cytopathogenicity by 50%. | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 10. | ALA671427 | F | Tested for the minimum inhibitory concentration required to reduce vesicular stomatitis virus(VSV) induced cytopathogenicity by 50% | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
| 11. | ALA674388 | F | Tested for the minimum cytotoxic concentration required to cause a microscopically detectable alteration of normal cell morphology in human embryonic skin muscle (E6SM) fibroblast cell cultures. | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 12. | ALA689612 | F | Antiviral activity against HIV-1 was determined; No inhibition | Human immunodeficiency virus 1 | 15 | organism-based format | Scientific Literature | ||
| 13. | ALA695295 | F | Antiviral activity of the compound, determined by plaque-reduction assay against Herpes simplex virus (HSV) type 1, BW5 strain in Vero cells | Human alphaherpesvirus 1 | 4 | organism-based format | Scientific Literature | ||
| 14. | ALA695296 | F | Antiviral activity of the compound, determined by plaque-reduction assay against thymidine kinase deficient Herpes simplex virus type 1, Z826 strain in Vero cells | Human alphaherpesvirus 1 | 3 | organism-based format | Scientific Literature | ||
| 15. | ALA695776 | F | Antiviral activity determined by plaque-reduction assay against Herpes simplex virus type 2, G strain in Vero cells | Human alphaherpesvirus 2 | 4 | organism-based format | Scientific Literature | ||
| 16. | ALA697715 | F | Antiviral activity determined by plaque-reduction assay against Human cytomegalovirus, AD-169 strain in MRC-5 cells | Human betaherpesvirus 5 | 4 | organism-based format | Scientific Literature | ||
| 17. | ALA694016 | F | Antiviral activity against HCMV was determined; No inhibition | Human betaherpesvirus 5 | 15 | organism-based format | Scientific Literature | ||
| 18. | ALA719104 | F | Compound was tested in vitro for Minimum inhibitory concentration required to reduce CMV(AD-169) induced cytopathicity in Human MT-4 cells | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 19. | ALA719105 | F | Compound was tested in vitro for Minimum inhibitory concentration required to reduce CMV(Davis) induced cytopathicity in Human MT-4 cells | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 20. | ALA719107 | F | Compound was tested in vitro for Minimum inhibitory concentration required to reduce HSV-1 TK-(B2006) induced cytopathicity in Human MT-4 cells | Homo sapiens | 7 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!